RESEARCH USE ONLY — This article describes a compound studied in laboratory and pre-clinical research. It is not intended for human or animal administration.

GHK-Cu

Healing & Recovery Half-life: ~30 minutes Status: Research Compound

GHK-Cu

GHK-Cu is a naturally-occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine bound to copper). It has been studied in published research since the 1970s and is one of the most-researched copper peptides in the scientific literature.

BLUF — At a Glance

A naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine + copper), studied since the 1970s.

Primary research focus

  • Skin research — wound healing, remodeling, anti-aging
  • Hair-follicle signaling
  • Gene-expression and anti-inflammatory studies

Notes: Status: research compound — not FDA-approved. Half-life ~30 min. Human trial data limited; findings largely animal/in-vitro. For research purposes only.

Mechanism of Action

Published research shows GHK-Cu delivers copper to tissue and modulates multiple signaling pathways in research models — including tissue remodeling, wound repair signaling, antioxidant response, and gene expression modulation. Gene expression research has shown GHK-Cu affects a wide range of transcription in skin cell cultures. The copper delivery aspect is central to the mechanism — bioavailable copper is required for many enzymes involved in tissue repair research.

Research Applications

  • Skin research — the most-published area (wound healing, skin remodeling, anti-aging cosmetic research)
  • Wound healing research — foundational literature base
  • Hair follicle research — published work on follicle signaling
  • Gene expression research — broad transcriptional effects in cell culture
  • Anti-oxidant and anti-inflammatory research

Dosing Reference (Published Literature)

Research protocols reference both topical (the most-studied route in published cosmetic science literature) and systemic administration. Topical research concentrations are typically in the ppm range in published formulations. Systemic research dosing has referenced low microgram ranges subcutaneously.

Synergistic Compounds

  • BPC-157 — Both studied for tissue repair through different mechanisms.
  • TB-500 — Both contribute to tissue repair research via complementary pathways.
  • Epithalon — Both are studied in anti-aging research contexts.
  • Thymosin-Alpha-1 — Immune-aging research overlap.

Research Protocols Using This Compound

Key References

  • Pickart L, et al. — Foundational GHK-Cu research dating to the 1970s
  • Published cosmetic science literature on skin and hair research

⚠️ Research Use Only (RUO). For educational and research reference purposes only. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease or condition. Always consult a qualified healthcare professional before making health-related decisions.

Frequently Asked Questions

Is GHK-Cu FDA-approved?

No. GHK-Cu is not approved by the U.S. Food and Drug Administration for any clinical application. It remains classified as a research compound supplied for laboratory work only.

What does the research literature show about GHK-Cu?

The published research record for GHK-Cu is summarized in the body of this article and the citations section. Pre-clinical and animal-model studies make up the bulk of the literature; human trial data is limited and is noted explicitly where it exists.

What are the documented synergistic compounds for GHK-Cu research?

See the Related Research sidebar for compounds that appear alongside GHK-Cu in the published literature. Detailed synergy notes will populate during the next vault expansion pass.

Where can I source GHK-Cu for research purposes?

See the Where to Source section above for vendors that supply research-grade GHK-Cu. Listed vendors are affiliate partners of Peptide Manager Pro; we earn a small commission on referred orders at no additional cost to the buyer.

Is GHK-Cu safe for human or animal use?

GHK-Cu is sold for in vitro and laboratory research only. It is not intended for human or veterinary administration, and no safety determination for such use has been established by the U.S. Food and Drug Administration or any equivalent regulatory body.